Medicines for Malaria Venture (MMV)
Medicines for Malaria Venture (MMV)
Funding 14 project(s)
Jun 2013 to May 2016
Modeling of different potential implementations of existing ACTs and other anti-malarial products in development
Oct 2014 to Apr 2015
MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
Dec 2014 to Dec 2015
Electrocardiographic safety evaluation of monthly dihydroartemisin-piperaquine for the use in mass treatment campaigns to block malaria transmission in Lihir island, Papua New Guinea
Malawi-Liverpool-Wellcome Trust Clinical Research Programme (MLW), Liverpool School of Tropical Medicine (LSTM) | Dianne Janette (Anja) Terlouw, Arantxa Roca-Feltrer
May 2010 to Apr 2014
Rolling Malaria Indicator Survey (rMIS) - Sub-national intervention coverage and malaria impact estimates in young children and older age groups using a continuous Malaria Indicator Survey
Jul 2014 to Oct 2015
Multicentre Phase IIb Study to Investigate the Efficacy of OZ439 & Piperaquine Phosphate Co-administered to Adults & Children With Uncomplicated Plasmodium Falciparum
Mahidol Oxford Tropical Medicine Research Unit (MORU) , Mahidol University | François Nosten, Sasithon Pukrittayakamee
Mar 2013 to Apr 2015
Extended Observation Over a Period of 28 Days of the Effects of Single Doses of OZ439 on the Recrudescence of Plasmodium Falciparum Malaria - a PhIIa, Open Label Study in Adult Patients
Leading 6 project(s)
Apr 2015 to Jul 2015
Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets
Partnering on 21 project(s)
Apr 2015 to Mar 2017
Discovery and planning Plasmodium falciparum enolase inhibitors as new antimalarial agents
Jul 2015 to Jun 2020
Dissecting the Red Blood Cell Invasion Pathways of the Malaria Parasite Plasmodium knowlesi
Doctor Heitor Vieira Dourado Foundation for Tropical Medicine (FMT-HVD), Brazil | Marcus Vinícius G. de Lacerda
Jan 2011 to Mar 2015
A study to evaluate the efficacy, safety and tolerability of tafenoquine (TQ) in subjects with plasmodium vivax in Brazil as part of detective multicentre trial.
Aug 2011 to Jul 2012
Safety, Immunogenicity and Efficacy Against Malaria in the Sporozoite Challenge Model of One Dose of Ad35.CS.01 Malaria Vaccine Followed by Two Doses of Malaria 257049 Vaccine in Healthy Malaria-naïve Adults